Nebenwirkungen · Neupro
Neupro 2 mg/24 h transdermal patch · Abschnitt 4.8 · PDF-Seite 22–23
HOS-114698 · Präparat HOS-094135
22 General Application and Irritability, disorders and instillation site oedema administration reactionsa (incl. peripheral site conditions erythema, pruritus, irritation, rash, dermatitis, vesicles, pain, eczema, inflammation, swelling, discolouration, papules, exfoliation, urticaria, hypersensitivity), asthenic conditionsa (incl. fatigue, asthenia, malaise) Investigations Weight decreasede, hepatic enzyme increasede (incl. AST, ALT, GGT), weight increasede, heart rate increasede, CPK increasedd,e Injury, Falle poisoning and procedural complications Musculoskeletal Rhabdomyolysisc and connective tissue disorders a High Level Term b Observed in open-label studies c Observed during post-marketing d Observed in 2011 data pool of double-blind placebo-controlled studies e Observed in studies performed in patients with Parkinson’s disease
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-04-07T15:00:00Z · SHA-256 8c1c13f4377b291e92778d0cf7bf84640db85e338315a5f9bf30e0c0a33c9a3d · Passage 70d630afb165708067d43709b706cde4ff2b9c1ed01ade75829660b93e7c9cb2 · Zeichen 7827–10026 im Abschnitt